An observational study in Spinal Deformity and Hemothorax Postoperative, sponsored by Gazi University. Completed at 1 site in Turkey. Open to participants aged 1 Year to 18 Years. Per ClinicalTrials.gov, last updated 2022-10-14.
Sponsored by Gazi University · Observational
Owing to the development of instruments and surgical techniques, the number of spinal deformity correction surgeries has increased significantly. The incidence of hemothorax due to posterior correction surgery for spinal deformity is reported to be as low as 0.1%, and the vast majority of these cases were treated through observation without additional intervention. However, if hemothorax that occurs is missed, it can result in increased mortality and morbidity. Furthermore, there is a paucity of data on management of hemothorax caused by posterior correction surgery. The aim of this retrospective study is to evaluate our cases of hemothorax after posterior correction surgery for spinal deformity.
We retrospectively reviewed medical records of all pediatric patients who underwent posterior correction surgery from 2016 to 2021.
26 studies on the registry are indexed under Hemothorax; 5 are open to participants now.
Browse Hemothorax studies →Gazi University is the lead sponsor of 551 studies on the registry; 102 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Children who underwent posterior correction surgery for spinal deformities (age range 1-18 years)
Exclusion Criteria:
-
Cases of hemothorax developing after posterior correction surgery for spinal deformities
hemothorax
hemothorax caused by posterior correction surgery for spinal deformity
Time frame: 2016-2021
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.